Hereditary Ocular Diseases
Published on Hereditary Ocular Diseases (https://disorders.eyes.arizona.edu)

Home > Bietti Crystalline Corneoretinal Dystrophy

Bietti Crystalline Corneoretinal Dystrophy

Clinical Characteristics
Ocular Features: 

The retina contains refractile glistening intraretinal crystals at all levels and choroidal vessels are said to be sclerosed.  The RPE atrophies and often forms pigment clumps.  The yellow-white crystals may be seen in the peripheral cornea and in the limbus.  Symptoms of night blindness and early vision loss begin about the third decade.  Night blindness is progressive as is the narrowing of the visual fields but this is highly variable between patients.  The visual field may show paracentral scotomas at some stage.  Central acuity can be normal until late in the disease when it becomes markedly impaired. Legal blindness can occur by the 5th decade of life. 

The ERG may show lack of rod and cone responses late in the disease and color vision may be lost.  However, the ffERG and mfERGs show decreases in amplitude of scotopic and photopic responses in all patients, even younger ones.  The EOG becomes abnormal in late stages.  The degree of involvement may be asymmetrical.  Complex lipid inclusions can be seen histologically in choroidal, conjunctival and skin fibroblasts, as well as in keratocytes and lymphocytes.

Crystalline deposits have been detected mostly in the proximal portions of RPE cells adjacent to degenerated retinal  areas.  Most common are circular hyperrefractive structures in the outer nuclear layer adjacent to areas of degeneration.  Some patients have cystoid macular edema. Others in late stages have fundus changes that resemble choroideremia.

Systemic Features: 

No other organ disease has been reported.

Genetics

This is an autosomal recessive disorder caused by mutations in the CYP4V2 [1] gene (4q35.1) involved in fatty acid metabolism.

A homozygous CYP4V2 [1] mutation has also been reported in patients with a choroideremia-like clinical phenotype.

Treatment
Treatment Options: 

No treatment beyond low vision aids is available.

References
Article Title: 

A novel homozygous CYP4V2 variant (p.S121Y) associated with a choroideremia-like phenotype [2]

Katagiri S, Hayashi T, Gekka T, Tsuneoka H. A novel homozygous CYP4V2 variant (p.S121Y) associated with a choroideremia-like phenotype. Ophthalmic Genet. 2016 Jun 27:1-2.

PubMed ID: 
27348340

Detailed functional and structural phenotype of Bietti crystalline dystrophy [3]

Fuerst NM, Serrano L, Han G, Morgan JI, Maguire AM, Leroy BP, Kim BJ, Aleman
TS. Detailed functional and structural phenotype of Bietti crystalline dystrophy
associated with mutations in CYP4V2 complicated by choroidal neovascularization.

Ophthalmic Genet. 2016 Mar 30:1-8.
 

PubMed ID: 
27028354

Cystoid Macular Edema in Bietti's Crystalline Retinopathy [4]

Saatci AO, Doruk HC, Yaman A. Cystoid Macular Edema in Bietti's Crystalline Retinopathy. Case Rep Ophthalmol Med. 2014.  Epub 2014 May 11.

PubMed ID: 
24949209

Bietti Crystalline Dystrophy [5]

Okialda KA, Stover NB, Weleber RG, Kelly EJ. Bietti Crystalline Dystrophy.
2012 Apr 12. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors.
GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-.
Available from http://www.ncbi.nlm.nih.gov/books/NBK91457/ [6].
 

PubMed ID: 
22497028

Outer retinal circular structures in patients with Bietti crystalline retinopathy [7]

Kojima H, Otani A, Ogino K, Nakagawa S, Makiyama Y, Kurimoto M, Guo C, Yoshimura N. Outer retinal circular structures in patients with Bietti crystalline retinopathy. Br J Ophthalmol. 2011 Jul 29. [Epub ahead of print]

PubMed ID: 
21803923

Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2 [8]

Li A, Jiao X, Munier FL, Schorderet DF, Yao W, Iwata F, Hayakawa M, Kanai A, Shy Chen M, Alan Lewis R, Heckenlively J, Weleber RG, Traboulsi EI, Zhang Q, Xiao X, Kaiser-Kupfer M, Sergeev YV, Hejtmancik JF. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet. 2004 May;74(5):817-26. Epub 2004 Mar 23.

PubMed ID: 
15042513

Electrophysiological findings in Bietti's crystalline dystrophy [9]

Sen P, Ray R, Ravi P. Electrophysiological findings in Bietti's crystalline dystrophy. Clin Exp Optom. 2011 May;94(3):302-8. Epub 2011 Apr 13

PubMed ID: 
21488952
College of Medicine Copyright © 2010 - 2016 Arizona Board of Regents

Source URL:https://disorders.eyes.arizona.edu/disorders/bietti-crystalline-corneoretinal-dystrophy

Links
[1] http://ghr.nlm.nih.gov/gene/CYP4V2 [2] https://disorders.eyes.arizona.edu/references/novel-homozygous-cyp4v2-variant-ps121y-associated-choroideremia-phenotype [3] https://disorders.eyes.arizona.edu/references/detailed-functional-and-structural-phenotype-bietti-crystalline-dystrophy [4] https://disorders.eyes.arizona.edu/references/cystoid-macular-edema-biettis-crystalline-retinopathy [5] https://disorders.eyes.arizona.edu/references/bietti-crystalline-dystrophy [6] http://www.ncbi.nlm.nih.gov/books/NBK91457/ [7] https://disorders.eyes.arizona.edu/references/outer-retinal-circular-structures-patients-bietti-crystalline-retinopathy [8] https://disorders.eyes.arizona.edu/references/bietti-crystalline-corneoretinal-dystrophy-caused-mutations-novel-gene-cyp4v2 [9] https://disorders.eyes.arizona.edu/references/electrophysiological-findings-biettis-crystalline-dystrophy